首页> 美国卫生研究院文献>MedChemComm >Design synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents
【2h】

Design synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents

机译:粉防己碱衍生物作为潜在抗癌药的设计合成及生物活性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Twenty-four 14-sulfonamide–tetrandrine derivatives as potential anti-cancer agents were synthesized. The synthetic derivatives were investigated for their cytotoxic activity against human cancer cell lines MDA-MB-231, PC3, WM9, HEL and K562. Initially, the IC50 values (50% inhibitory concentrations) of all of the compounds were determined. These derivatives exhibited potent, but distinct, inhibitory effects on the above-mentioned cell lines. Among them, compound >23, which was modified with a 2-naphthalenesulfonyl group at the 14-amino position, showed impressive inhibition of all five cancer cell lines, and especially of MDA-MB-231 cells with an IC50 value of 1.18 ± 0.14 μM. Further mechanism exploration showed that >23 induced potent apoptotic cell death on MDA-MB-231 cancer cells in a concentration-dependent manner. The results revealed that >23 might be a potential anti-cancer drug candidate.
机译:合成了二十四种14-磺酰胺-粉防己碱衍生物作为潜在的抗癌药。研究了合成衍生物对人癌细胞系MDA-MB-231,PC3,WM9,HEL和K562的细胞毒活性。最初,确定所有化合物的IC 50值(50%抑制浓度)。这些衍生物对上述细胞系表现出有效的但独特的抑制作用。其中,化合物> 23 (在14-氨基位置被2-萘磺酰基修饰)对所有5种癌细胞系,尤其是对MDA-MB-231细胞具有明显的抑制作用。 IC50值为1.18±0.14μM。进一步的机制探索表明,> 23 以浓度依赖性方式诱导MDA-MB-231癌细胞有效凋亡。结果显示,> 23 可能是潜在的抗癌药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号